Abstract CT321: First results of a 10-day regimen of SGI-110 (guadecitabine), a second generation hypomethylating agent (HMA) in previously untreated elderly AML who are not candid... von Roboz, Gail, Kantarjian, Hagop, Kropf, Patricia, Richie, Ellen, Jain, Nitin, Griffiths, Elizabeth, Podoltsev, Nikola A., Walsh, Katherine, O'Connell, Casey, Stock, Wendy, Rizzieri, David, Tibes, Raoul, Rosenblat, Todd, Chung, Woonbok, Taverna, Pietro, Su, Xiang Yao, Naim, Sue, Azab, Mohammad, Issa, Jean-Pierre

Volltext